Person

Mark E. Delaney

SVP & Chief Commercial Officer, Quest Diagnostics

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$2.3M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Jul 28, 2026DGXSale1,600$235.18$376K
Nov 18, 2025DGXSale7,946$187.35$1.5M
May 13, 2025DGXSale874$175.31$153K
May 12, 2025DGXSale874$175.72$154K
Feb 5, 2025DGXSale403$164.30$66K
Jul 24, 2024DGXSale420$143.08$60K

SEC reporting-owner ID (CIK) 1955265 · all filings on EDGAR